Addressing high unmet medical needs.

We have generated a robust pipeline of assets focusing our platform towards areas of high unmet medical needs, aiming to expand the impact of gene therapy.

Our lead program is in the area of immuno-oncology, with additional programs focused on diseases of the respiratory, urogenital, and gastrointestinal mucosal tissues.